CRP and COVID-19: Findings from the analysis of clinical laboratory indicators suggest that the patients with moderate COVID-19 exhibited a more pronounced inflammatory response than those with mild COVID-19, as evidenced by their elevated neutrophil counts and increased levels of inflammatory markers such as CRP and LDH.